Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 99.920 | 99.920 | 0.000 |
Other | 0.110 | 0.110 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 13.925 | 14.923 |
Price to Book | 1.657 | 1.944 |
Price to Sales | 1.026 | 1.291 |
Price to Cash Flow | 7.697 | 8.654 |
Dividend Yield | 2.153 | 2.091 |
5 Years Earnings Growth | 13.483 | 12.307 |
Name | Net % | Category Average |
---|---|---|
Industrials | 18.790 | 21.435 |
Financial Services | 14.770 | 11.917 |
Consumer Cyclical | 13.830 | 15.142 |
Technology | 13.080 | 15.981 |
Healthcare | 9.550 | 11.302 |
Real Estate | 8.270 | 4.817 |
Basic Materials | 6.280 | 6.454 |
Consumer Defensive | 5.070 | 5.613 |
Energy | 4.320 | 6.117 |
Communication Services | 3.240 | 4.502 |
Utilities | 2.800 | 2.211 |
Number of long holdings: 6,548
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Carvana | US1468691027 | 0.34 | 223.89 | +0.58% | |
State Street Us Treasury Liqui | - | 0.25 | - | - | |
Tenet Healthcare | US88033G4073 | 0.17 | 129.71 | +0.05% | |
Snap-On | US8330341012 | 0.16 | 345.43 | +0.31% | |
Toll Brothers | US8894781033 | 0.16 | 127.87 | +0.67% | |
CAVA Group | US1489291021 | 0.16 | 118.52 | +0.58% | |
Natera Inc | US6323071042 | 0.16 | 162.39 | +0.25% | |
Incyte | US45337C1027 | 0.15 | 69.91 | +0.10% | |
Coherent | US19247G1076 | 0.15 | 99.78 | +0.77% | |
United Therapeutics | US91307C1027 | 0.15 | 360.87 | -0.76% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IE00B2PC0930 | 5.81B | 15.50 | 10.23 | 9.72 | ||
IE00B5SRBK47 | 3.57B | 17.01 | 8.74 | 10.24 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review